11 papers this month, including an announcement that naloxone is now over-the-counter in Australia.
Evans TI, Hadland SE,
Clark MA, Green TC, Marshall BD.
Harm Reduct J. 2016 Jul
26;13(1):24. doi: 10.1186/s12954-016-0113-2.
Comments: Less than half
knew about it.
Stein MD, Kanabar M,
Anderson BJ, Lembke A, Bailey GL.
J Subst Abuse Treat.
2016 Sep;68:57-61. doi: 10.1016/j.jsat.2016.06.008. Epub 2016 Jun 16.
Comments: Important
work, as there’s an effort to also reduce benzodiazepine prescribing among
people who are on opioids. Understanding the drivers of BDZ use should be
helpful in structuring interventions. Anxiety and managing opioid withdrawal
were two main reasons.
Jones CM, Baldwin GT,
Manocchio T, White JO, Mack KA.
MMWR Morb Mortal Wkly
Rep. 2016 Jul 8;65(26):667-71. doi: 10.15585/mmwr.mm6526a2.
Comments: Interesting
analysis of methadone prescribing, overdose, and diversion. It seems that
efforts to reduce methadone, beginning in 2006, corresponded with reduced
diversion and overdose; unfortunate that opioid overdose death overall
continued to escalate.
Makarenko I, Mazhnaya A,
Polonsky M, Marcus R, Bojko MJ, Filippovych S, Springer S, Dvoriak S, Altice
FL.
Drug Alcohol Depend.
2016 Aug 1;165:213-20. doi: 10.1016/j.drugalcdep.2016.06.011. Epub 2016 Jun 17.
Comments: Barriers to
enrolling in agonist treatment in Ukraine.